Showing results 2318 to 2337 of 6339
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 1997 | From delivery suite to laboratory: optimizing returns from placental examination in medico-legal defence | Khong, Teck Yee |
| 2016 | From postpartum haemorrhage guideline to local protocol: a study of protocol quality | Woiski, M.; van Vugt, H.; Dijkman, A.; Grol, R.; Marcus, A.; Middeldorp, J.; Mol, B.; Mols, F.; Oudijk, M.; Porath, M.; Scheepers, H.; Hermens, R. |
| 1997 | Fronto-facio-nasal dysplasia | Suthers, G.; David, D.; Clark, B. |
| 2013 | Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis | Dobson-Stone, C.; Luty, A.; Thompson, E.; Blumbergs, P.; Brooks, W.; Short, C.; Field, C.; Panegyres, P.; Hecker, J.; Solski, J.; Blair, I.; Fullerton, J.; Halliday, G.; Schofield, P.; Kwok, J. |
| 2001 | Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception | Wang, X.; Yap, Y.; Matthews, C. |
| 2010 | Functional analysis of the HGSNAT gene in patients with Mucopolysaccharidosis IIIC (Sanfilippo C Syndrome) | Fedele, A.; Hopwood, J. |
| 2006 | Functional central rhythmicity and light entrainment, but not liver and muscle rhythmicity, are Clock independent | Kennaway, D.; Owens, J.; Voultsios, A.; Varcoe, T. |
| 2007 | Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor | Ali, A.; Christie, P.; Grigorieva, I.; Harding, B.; Van Esch, H.; Ahmed, S.; Bitner-Glindzicz, M.; Blind, E.; Bloch, C.; Christin, P.; Clayton, P.; Gecz, J.; Gilbert-Dussardier, B.; Guillen-Navarro, E.; Hackett, A.; Halac, I.; Hendy, G.; Lalloo, F.; Mache, C.; Mughal, Z.; et al. |
| 2007 | Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis | Bai, H.; Grist, S.; Gardner, J.; Suthers, G.; Wilson, T.; Lu, A. |
| 2011 | Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability | Melko, M.; Douguet, D.; Bensaid, M.; Zongaro, S.; Verheggen, C.; Gecz, J.; Bardoni, B. |
| 2007 | Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes | Fraldi, A.; Hemsley, K.; Crawley, A.; Lombardi, A.; Lau, A.; Sutherland, L.; Auricchio, A.; Ballabio, A.; Hopwood, J. |
| 2013 | Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production | Glister, C.; Satchell, L.; Bathgate, R.; Wade, J.; Dai, Y.; Ivell, R.; Anand Ivell, R.; Rodgers, R.; Knight, P. |
| 1999 | Functional lymphocyte immunophenotypes observed in thalassaemia and haemophilia patients receiving current blood product preparations | Hodge, G.; Lloyd, J.; Hodge, S.; Story, C.; Han, P. |
| 2008 | Functional neuroimaging and withdrawal of life-sustaining treatment from vegetative patients | Wilkinson, D.; Kahane, G.; Horne, M.; Savulescu, J. |
| 2011 | Functional performance in young Australian children with achondroplasia | Ireland, P.; McGill, J.; Zankl, A.; Ware, R.; Pacey, V.; Ault, J.; Savarirayan, R.; Sillence, D.; Thompson, E.; Townshend, S.; Johnston, L. |
| 2005 | Funnel-web spider bite: a systematic review of recorded clinical cases | Isbister, G.; Gray, M.; Balit, C.; Raven, R.; Stokes, B.; Porges, K.; Tankel, A.; Turner, E.; White, J.; Fisher, M. |
| 1996 | Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25) | Gibson, M.; Hatzinikolas, G.; Kumaratilake, J.; Sandberg, L.; Nicholl, J.; Sutherland, G.; Cleary, E. |
| 2013 | Futile treatment: the ethicist's perspective | Wilkinson, D.J.C. |
| 2004 | Future Directions for Mammalian Cloning | Nottle, M.; Beebe, L.; Harrison, S.; Faast, R.; Moretta, M.; McIlfatrick, S. |
| 2012 | Future long-term trials of postmenopausal hormone replacement therapy: what is possible and what is the optimal protocol and regimen? | Purbrick, B.; Stranks, K.; Sum, C.; MacLennan, A. |
